カテゴリー： QYResearch, 世界

世界のオキシカルバゼピンAPI産業：成長傾向・競合分析

◆英語タイトル：Global Oxcarbazepine API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
◆商品コード：DATA909X01692
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：135
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥725,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,087,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,450,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のオキシカルバゼピンAPI市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。オキシカルバゼピンAPIの種類別には、医療用、その他に、用途別には、タブレット、経口懸濁液、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・オキシカルバゼピンAPIの種類別市場規模：医療用、その他
・オキシカルバゼピンAPIの用途別市場規模：タブレット、経口懸濁液、その他
・オキシカルバゼピンAPIの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Novartis、Sun Pharm、Apotex、Jubilant Pharma、Mylan、Hetero、Teva、BASF、Glenmark、Dr. Reddy’s、F.I.S.(Fabbrica Italiana Sintetici)、Euticals、Taro Pharmaceuticals、Humanwell、Zhejiang Jiuzhou Pharmaceutical、CTX Life Sciences、VPL Chemicals、Amoli Organics、Bajaj Healthcare、MSN Laboratories、Shizuoka caffeine、Anuja Healthcare、Taj Pharmaceuticals、Yamamoto Chemical
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

【レポートの概要】

Oxcarbazepine API (CAS# 28721-07-05 ) is solid and used in anticonvulsant Industry. Oxcarbazepine is an anticonvulsant agent generally used in the treatment of partial seizures in children and adults with epilepsy. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. In 2018, the global Oxcarbazepine API market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oxcarbazepine API.

This study researches the market size of Oxcarbazepine API, presents the global Oxcarbazepine API sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Oxcarbazepine API in key regions like North America, Europe, China and India, presents sales, revenue, market share, growth rate of Oxcarbazepine API for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Sun Pharm
Apotex
Jubilant Pharma
Mylan
Hetero
Teva
BASF
Glenmark
Dr. Reddy’s
F.I.S.(Fabbrica Italiana Sintetici)
Euticals
Taro Pharmaceuticals
Humanwell
Zhejiang Jiuzhou Pharmaceutical
CTX Life Sciences
VPL Chemicals
Amoli Organics
Bajaj Healthcare
MSN Laboratories
Shizuoka caffeine
Anuja Healthcare
Taj Pharmaceuticals
Yamamoto Chemical

Market Segment by Product Type
Medical Grade
Other

Market Segment by Application
Tablets
Oral Suspension
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Oxcarbazepine API status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Oxcarbazepine API manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oxcarbazepine API are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oxcarbazepine API Market Size Growth Rate by Type
1.3.2 Medical Grade
1.3.3 Other
1.4 Market Segment by Application
1.4.1 Global Oxcarbazepine API Market Share by Application (2019-2025)
1.4.2 Tablets
1.4.3 Oral Suspension
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Oxcarbazepine API Market Size
2.1.1 Global Oxcarbazepine API Revenue 2014-2025
2.1.2 Global Oxcarbazepine API Sales 2014-2025
2.2 Oxcarbazepine API Growth Rate by Regions
2.2.1 Global Oxcarbazepine API Sales by Regions 2014-2019
2.2.2 Global Oxcarbazepine API Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Oxcarbazepine API Sales by Manufacturers
3.1.1 Oxcarbazepine API Sales by Manufacturers 2014-2019
3.1.2 Oxcarbazepine API Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Oxcarbazepine API Revenue by Manufacturers (2014-2019)
3.2.2 Oxcarbazepine API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Oxcarbazepine API Market Concentration Ratio (CR5 and HHI)
3.3 Oxcarbazepine API Price by Manufacturers
3.4 Key Manufacturers Oxcarbazepine API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oxcarbazepine API Market
3.6 Key Manufacturers Oxcarbazepine API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Medical Grade Sales and Revenue (2014-2019)
4.1.2 Other Sales and Revenue (2014-2019)
4.2 Global Oxcarbazepine API Sales Market Share by Type
4.3 Global Oxcarbazepine API Revenue Market Share by Type
4.4 Oxcarbazepine API Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Oxcarbazepine API Sales by Application

6 North America
6.1 North America Oxcarbazepine API Breakdown Data by Company
6.2 North America Oxcarbazepine API Breakdown Data by Type
6.3 North America Oxcarbazepine API Breakdown Data by Application
6.4 North America Oxcarbazepine API Breakdown Data by Countries
6.4.1 North America Oxcarbazepine API Sales by Countries
6.4.2 North America Oxcarbazepine API Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Oxcarbazepine API Breakdown Data by Company
7.2 Europe Oxcarbazepine API Breakdown Data by Type
7.3 Europe Oxcarbazepine API Breakdown Data by Application
7.4 Europe Oxcarbazepine API Breakdown Data by Countries
7.4.1 Europe Oxcarbazepine API Sales by Countries
7.4.2 Europe Oxcarbazepine API Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Oxcarbazepine API Breakdown Data by Company
8.2 Asia Pacific Oxcarbazepine API Breakdown Data by Type
8.3 Asia Pacific Oxcarbazepine API Breakdown Data by Application
8.4 Asia Pacific Oxcarbazepine API Breakdown Data by Regions
8.4.1 Asia Pacific Oxcarbazepine API Sales by Countries
8.4.2 Asia Pacific Oxcarbazepine API Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Oxcarbazepine API Breakdown Data by Company
9.2 Central & South America Oxcarbazepine API Breakdown Data by Type
9.3 Central & South America Oxcarbazepine API Breakdown Data by Application
9.4 Central & South America Oxcarbazepine API Breakdown Data by Countries
9.4.1 Central & South America Oxcarbazepine API Sales by Countries
9.4.2 Central & South America Oxcarbazepine API Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Oxcarbazepine API Breakdown Data by Type
10.2 Middle East and Africa Oxcarbazepine API Breakdown Data by Application
10.3 Middle East and Africa Oxcarbazepine API Breakdown Data by Countries
10.3.1 Middle East and Africa Oxcarbazepine API Sales by Countries
10.3.2 Middle East and Africa Oxcarbazepine API Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.1.4 Oxcarbazepine API Product Introduction
11.1.5 Novartis Recent Development
11.2 Sun Pharm
11.2.1 Sun Pharm Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.2.4 Oxcarbazepine API Product Introduction
11.2.5 Sun Pharm Recent Development
11.3 Apotex
11.3.1 Apotex Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.3.4 Oxcarbazepine API Product Introduction
11.3.5 Apotex Recent Development
11.4 Jubilant Pharma
11.4.1 Jubilant Pharma Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.4.4 Oxcarbazepine API Product Introduction
11.4.5 Jubilant Pharma Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.5.4 Oxcarbazepine API Product Introduction
11.5.5 Mylan Recent Development
11.6 Hetero
11.6.1 Hetero Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.6.4 Oxcarbazepine API Product Introduction
11.6.5 Hetero Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.7.4 Oxcarbazepine API Product Introduction
11.7.5 Teva Recent Development
11.8 BASF
11.8.1 BASF Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.8.4 Oxcarbazepine API Product Introduction
11.8.5 BASF Recent Development
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.9.4 Oxcarbazepine API Product Introduction
11.9.5 Glenmark Recent Development
11.10 Dr. Reddy’s
11.10.1 Dr. Reddy’s Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Oxcarbazepine API
11.10.4 Oxcarbazepine API Product Introduction
11.10.5 Dr. Reddy’s Recent Development
11.11 F.I.S.(Fabbrica Italiana Sintetici)
11.12 Euticals
11.13 Taro Pharmaceuticals
11.14 Humanwell
11.15 Zhejiang Jiuzhou Pharmaceutical
11.16 CTX Life Sciences
11.17 VPL Chemicals
11.18 Amoli Organics
11.19 Bajaj Healthcare
11.20 MSN Laboratories
11.21 Shizuoka caffeine
11.22 Anuja Healthcare
11.23 Taj Pharmaceuticals
11.24 Yamamoto Chemical

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Oxcarbazepine API Sales Channels
12.2.2 Oxcarbazepine API Distributors
12.3 Oxcarbazepine API Customers

13 Market Forecast
13.1 Global Oxcarbazepine API Sales and Revenue Forecast 2019-2025
13.2 Global Oxcarbazepine API Sales Forecast by Type
13.3 Global Oxcarbazepine API Sales Forecast by Application
13.4 Oxcarbazepine API Forecast by Regions
13.4.1 Global Oxcarbazepine API Sales Forecast by Regions 2019-2025
13.4.2 Global Oxcarbazepine API Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Oxcarbazepine API Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Oxcarbazepine API Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Oxcarbazepine API Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Oxcarbazepine API Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Oxcarbazepine API Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Oxcarbazepine API Product Picture
Table Oxcarbazepine API Key Market Segments
Table Major Manufacturers Oxcarbazepine API Covered in This Report
Table Global Oxcarbazepine API Market Size Growth Rate by Type 2019-2025 (MT) & (Million US$)
Figure Global Oxcarbazepine API Sales Market Shar by Type 2014-2025
Figure Medical Grade Figures
Table Major Manufacturers of Medical Grade
Figure Other Figures
Table Major Manufacturers of Other
Table Global Oxcarbazepine API Market Share by Application 2019-2025 (MT)
Figure Tablets Use Case
Figure Oral Suspension Use Case
Figure Other Use Case
Figure Oxcarbazepine API Report Years Considered
Figure Global Oxcarbazepine API Market Size 2014-2025 (Million US$)
Figure Global Oxcarbazepine API Sales 2014-2019 (MT)
Table Global Oxcarbazepine API Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Oxcarbazepine API Sales by Regions 2014-2019 (MT)
Table Global Oxcarbazepine API Sales Market Share by Regions 2014-2019
Figure Global Oxcarbazepine API Sales Market Share by Regions 2014-2019
Figure Global Oxcarbazepine API Sales Market Share by Regions in 2018
Table Global Oxcarbazepine API Revenue by Regions 2014-2019 (Million US$)
Table Global Oxcarbazepine API Revenue Market Share by Regions 2014-2019
Figure Global Oxcarbazepine API Revenue Market Share by Regions 2014-2019
Figure Global Oxcarbazepine API Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Oxcarbazepine API Sales by Manufacturers (2014-2019) (MT)
Table Global Oxcarbazepine API Sales Share by Manufacturers (2014-2019)
Figure Global Oxcarbazepine API Sales Share by Manufacturers in 2018
Table Oxcarbazepine API Revenue by Manufacturers (2014-2019) (Million USD)
Table Oxcarbazepine API Revenue Share by Manufacturers (2014-2019)
Figure Oxcarbazepine API Value Share by Manufacturers in 2018
Table Global Oxcarbazepine API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oxcarbazepine API Price (2014-2019) (USD/Kg)
Table Key Manufacturers Oxcarbazepine API Plants/Factories Distribution
Table Key Manufacturers Oxcarbazepine API Area Served
Table Date of Key Manufacturers Enter into Oxcarbazepine API Market
Table Key Manufacturers Oxcarbazepine API Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Medical Grade Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Other Sales an目录输出!D Revenue (2014-2019) (MT) & (Million US$)
Table Global Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table Global Oxcarbazepine API Sales Share by Type (2014-2019)
Figure Global Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure Global Oxcarbazepine API Sales Market Share by Type in 2018
Table Global Oxcarbazepine API Revenue by Type (2014-2019) (Million US$)
Table Global Oxcarbazepine API Revenue Share by Type (2014-2019)
Figure Global Oxcarbazepine API Revenue Market Share by Type (2014-2019)
Figure Global Oxcarbazepine API Revenue Market Share by Type in 2018
Table Oxcarbazepine API Price by Type 2014-2019 (USD/Kg)
Table Global Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table Global Oxcarbazepine API Sales Share by Application (2014-2019)
Figure Global Sales Oxcarbazepine API Market Share by Application (2014-2019)
Figure Global Sales Oxcarbazepine API Market Share by Application in 2018
Figure North America Oxcarbazepine API Sales Growth Rate 2014-2019 (MT)
Figure North America Oxcarbazepine API Revenue Growth Rate 2014-2019 (Million US$)
Table North America Oxcarbazepine API Sales by Company (2014-2019) (MT)
Table North America Oxcarbazepine API Sales Market Share by Company (2014-2019)
Figure North America Oxcarbazepine API Sales Market Share by Company in 2018
Table North America Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table North America Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure North America Oxcarbazepine API Market Share by Type in 2018
Table North America Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table North America Oxcarbazepine API Sales Market Share by Application (2014-2019)
Figure North America Oxcarbazepine API Market Share by Application in 2018
Table North America Oxcarbazepine API Sales by Countries (2014-2019) (MT)
Table North America Oxcarbazepine API Sales Market Share by Countries (2014-2019)
Figure North America Oxcarbazepine API Sales Market Share by Countries in 2018
Table North America Oxcarbazepine API Revenue by Countries (2014-2019) (Million US$)
Table North America Oxcarbazepine API Revenue Market Share by Countries (2014-2019)
Figure North America Oxcarbazepine API Revenue Market Share by Countries in 2018
Figure United States Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Canada Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Mexico Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Europe Oxcarbazepine API Sales Growth Rate 2014-2019 (MT)
Figure Europe Oxcarbazepine API Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Oxcarbazepine API Sales by Company (2014-2019) (MT)
Table Europe Oxcarbazepine API Sales Market Share by Company (2014-2019)
Figure Europe Oxcarbazepine API Sales Market Share by Company in 2018
Table Europe Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table Europe Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure Europe Oxcarbazepine API Sales Market Share by Type in 2018
Table Europe Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table Europe Oxcarbazepine API Sales Market Share by Application (2014-2019)
Figure Europe Oxcarbazepine API Sales Market Share by Application in 2018
Table Europe Oxcarbazepine API Sales by Countries (2014-2019) (MT)
Table Europe Oxcarbazepine API Sales Market Share by Countries (2014-2019)
Figure Europe Oxcarbazepine API Sales Market Share by Countries in 2018
Table Europe Oxcarbazepine API Revenue by Countries (2014-2019) (Million US$)
Table Europe Oxcarbazepine API Revenue Market Share by Countries (2014-2019)
Figure Europe Oxcarbazepine API Revenue Market Share by Countries in 2018
Figure Germany Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure France Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure UK Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Italy Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Russia Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Asia Pacific Oxcarbazepine API Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Oxcarbazepine API Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Oxcarbazepine API Sales by Regions (2014-2019) (MT)
Table Asia Pacific Oxcarbazepine API Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine API Sales Market Share by Regions in 2018
Table Asia Pacific Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table Asia Pacific Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure Asia Pacific Oxcarbazepine API Market Share by Type in 2018
Table Asia Pacific Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table Asia Pacific Oxcarbazepine API Sales Market Share by Application (2014-2019)
Figure Asia Pacific Oxcarbazepine API Market Share by Application in 2018
Table Asia Pacific Oxcarbazepine API Sales by Countries (2014-2019) (MT)
Table Asia Pacific Oxcarbazepine API Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine API Sales Market Share by Regions in 2018
Table Asia Pacific Oxcarbazepine API Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Oxcarbazepine API Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Oxcarbazepine API Revenue Market Share by Regions in 2018
Figure China Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure China Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Japan Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Korea Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure India Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure India Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Australia Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Philippines Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Thailand Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Oxcarbazepine API Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Oxcarbazepine API Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Oxcarbazepine API Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Oxcarbazepine API Sales by Company (2014-2019) (MT)
Table Central & South America Oxcarbazepine API Sales Market Share by Company (2014-2019)
Figure Central & South America Oxcarbazepine API Sales Market Share by Company in 2018
Table Central & South America Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table Central & South America Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure Central & South America Oxcarbazepine API Market Share by Type in 2018
Table Central & South America Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table Central & South America Oxcarbazepine API Sales Market Share by Application (2014-2019)
Figure Central & South America Oxcarbazepine API Market Share by Application in 2018
Table Central & South America Oxcarbazepine API Sales by Countries (2014-2019) (MT)
Table Central & South America Oxcarbazepine API Sales Market Share by Countries (2014-2019)
Figure Central & South America Oxcarbazepine API Sales Market Share by Countries in 2018
Table Central & South America Oxcarbazepine API Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Oxcarbazepine API Revenue Market Share by Countries (2014-2019)
Figure Central & South America Oxcarbazepine API Revenue Market Share by Countries in 2018
Figure Brazil Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Brazil Oxcarbazepine API Revenue Growth Rate (2014-2019) (MT)
Figure Middle East and Africa Oxcarbazepine API Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Oxcarbazepine API Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Oxcarbazepine API Sales by Type (2014-2019) (MT)
Table Middle East and Africa Oxcarbazepine API Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Oxcarbazepine API Sales Market Share by Type in 2018
Table Middle East and Africa Oxcarbazepine API Sales by Application (2014-2019) (MT)
Table Middle East and Africa Oxcarbazepine API Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Oxcarbazepine API Sales Market Share by Application in 2018
Table Middle East and Africa Oxcarbazepine API Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Oxcarbazepine API Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Oxcarbazepine API Sales Market Share by Countries in 2018
Table Middle East and Africa Oxcarbazepine API Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Oxcarbazepine API Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oxcarbazepine API Revenue Market Share by Countries in 2018
Figure GCC Countries Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Oxcarbazepine API Revenue Growth Rate (2014-2019) (MT)
Figure Egypt Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure Egypt Oxcarbazepine API Revenue Growth Rate (2014-2019) (MT)
Figure South Africa Oxcarbazepine API Sales Growth Rate (2014-2019) (MT)
Figure South Africa Oxcarbazepine API Revenue Growth Rate (2014-2019) (MT)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Novartis Oxcarbazepine API Sales Market Share in Global Market
Table Novartis Recent Development
Table Sun Pharm Company Details
Table Sun Pharm Description and Business Overview
Table Sun Pharm Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Sun Pharm Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Sun Pharm Oxcarbazepine API Sales Market Share in Global Market
Table Sun Pharm Recent Development
Table Apotex Company Details
Table Apotex Description and Business Overview
Table Apotex Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Apotex Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Apotex Oxcarbazepine API Sales Market Share in Global Market
Table Apotex Recent Development
Table Jubilant Pharma Company Details
Table Jubilant Pharma Description and Business Overview
Table Jubilant Pharma Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Jubilant Pharma Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Jubilant Pharma Oxcarbazepine API Sales Market Share in Global Market
Table Jubilant Pharma Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Mylan Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Mylan Oxcarbazepine API Sales Market Share in Global Market
Table Mylan Recent Development
Table Hetero Company Details
Table Hetero Description and Business Overview
Table Hetero Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Hetero Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Hetero Oxcarbazepine API Sales Market Share in Global Market
Table Hetero Recent Development
Table Teva Company Details
Table Teva Description and Business Overview
Table Teva Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Teva Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Teva Oxcarbazepine API Sales Market Share in Global Market
Table Teva Recent Development
Table BASF Company Details
Table BASF Description and Business Overview
Table BASF Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table BASF Oxcarbazepine API Sales Growth Rate (2014-2019)
Table BASF Oxcarbazepine API Sales Market Share in Global Market
Table BASF Recent Development
Table Glenmark Company Details
Table Glenmark Description and Business Overview
Table Glenmark Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Glenmark Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Glenmark Oxcarbazepine API Sales Market Share in Global Market
Table Glenmark Recent Development
Table Dr. Reddy’s Company Details
Table Dr. Reddy’s Description and Business Overview
Table Dr. Reddy’s Oxcarbazepine API Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
Table Dr. Reddy’s Oxcarbazepine API Sales Growth Rate (2014-2019)
Table Dr. Reddy’s Oxcarbazepine API Sales Market Share in Global Market
Table Dr. Reddy’s Recent Development
Table F.I.S.(Fabbrica Italiana Sintetici) Company Details
Table Euticals Company Details
Table Taro Pharmaceuticals Company Details
Table Humanwell Company Details
Table Zhejiang Jiuzhou Pharmaceutical Company Details
Table CTX Life Sciences Company Details
Table VPL Chemicals Company Details
Table Amoli Organics Company Details
Table Bajaj Healthcare Company Details
Table MSN Laboratories Company Details
Table Shizuoka caffeine Company Details
Table Anuja Healthcare Company Details
Table Taj Pharmaceuticals Company Details
Table Yamamoto Chemical Company Details
Figure Oxcarbazepine API Value Chain
Table Oxcarbazepine API Distributors List
Table Oxcarbazepine API Customers List
Table Global Oxcarbazepine API Sales Forecast 2019-2025 (MT) & (Million US$)
Figure Global Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Global Oxcarbazepine API Revenue Forecast 2019-2025 (Million US$)
Table Global Oxcarbazepine API Sales Forecast by Type 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Forecast by Type 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Market Share Forecast by Type 2019-2025
Table Global Oxcarbazepine API Sales Forecast by Application 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Forecast by Application 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Market Share Forecast by Application 2019-2025
Table Global Oxcarbazepine API Sales Forecast by Regions 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Forecast by Regions 2019-2025 (MT)
Figure Global Oxcarbazepine API Sales Market Share Forecast by Regions 2019-2025
Table Global Oxcarbazepine API Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Oxcarbazepine API Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Oxcarbazepine API Revenue Market Share Forecast by Regions 2019-2025
Table North America Oxcarbazepine API Sales Forecast by Countries 2019-2025 (MT)
Table North America Oxcarbazepine API Sales Market Share Forecast by Countries 2019-2025
Table North America Oxcarbazepine API Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Oxcarbazepine API Revenue Market Share Forecast by Countries 2019-2025
Figure United States Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Canada Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Mexico Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Table Europe Oxcarbazepine API Sales Forecast by Countries 2019-2025 (MT)
Table Europe Oxcarbazepine API Sales Market Share Forecast by Countries 2019-2025
Table Europe Oxcarbazepine API Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Oxcarbazepine API Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure France Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure UK Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Italy Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Russia Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Table Asia Pacific Oxcarbazepine API Sales Forecast by Regions 2019-2025 (MT)
Table Asia Pacific Oxcarbazepine API Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Oxcarbazepine API Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Oxcarbazepine API Revenue Market Share Forecast by Regions 2019-2025
Figure China Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Japan Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure South Korea Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure India Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Australia Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Indonesia Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Thailand Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Malaysia Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Philippines Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Vietnam Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Table Central & South America Oxcarbazepine API Sales Forecast by Countries 2019-2025 (MT)
Table Central & South America Oxcarbazepine API Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Oxcarbazepine API Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Oxcarbazepine API Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Table Middle East and Africa Oxcarbazepine API Sales Forecast by Regions 2019-2025 (MT)
Table Middle East and Africa Oxcarbazepine API Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Oxcarbazepine API Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Oxcarbazepine API Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure GCC Countries Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure Egypt Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Figure South Africa Oxcarbazepine API Sales Forecast 2019-2025 (MT)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Novartis、Sun Pharm、Apotex、Jubilant Pharma、Mylan、Hetero、Teva、BASF、Glenmark、Dr. Reddy’s、F.I.S.(Fabbrica Italiana Sintetici)、Euticals、Taro Pharmaceuticals、Humanwell、Zhejiang Jiuzhou Pharmaceutical、CTX Life Sciences、VPL Chemicals、Amoli Organics、Bajaj Healthcare、MSN Laboratories、Shizuoka caffeine、Anuja Healthcare、Taj Pharmaceuticals、Yamamoto Chemical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオキシカルバゼピンAPI産業：成長傾向・競合分析(Global Oxcarbazepine API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp